BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• Medovex Corporation Files Form 8K Affirmatively Stating Current Compliance With NASDAQ’s Stockholders Equity Requirement

  February 27, 2017

   · 

  4 min read
• Drug Development

  Biothera Announces Presentation Of Clinical Data Supporting Use Of A Patient Selection Biomarker For Its Phase II Cancer Immunotherapy

  February 27, 2017

   · 

  2 min read
• Drug Development

  ASIT Biotech Will Publish The Results Of The Phase III Clinical Trial With Its Gp-ASIT+ Product Candidate For Treating Grass Pollen Rhinitis On 28 February, 2017

  February 27, 2017

   · 

  6 min read
• Business

  Lead Pharma Achieves Second Milestone For Development Of Autoimmune Diseases Treatments In Sanofi Collaboration

  February 27, 2017

   · 

  3 min read
• Drug Development

  NoNO, Inc Initiates Phase III Study Of NA-1 For Acute Ischemic Stroke

  February 27, 2017

   · 

  3 min read
• Genetown

  MilliporeSigma’s Integritest 5 Instrument Provides Integrity Testing, Assurance

  February 27, 2017

   · 

  1 min read
• Drug Development

  La Jolla Pharma’s Low Blood Pressure Med Meets Phase III Study Goals

  February 27, 2017

   · 

  7 min read
• Business

  Advaxis, SELLAS Life Sci Ink $358 Million Cancer Immunotherapy R&D Pact

  February 27, 2017

   · 

  7 min read
• Business

  Seattle’s CTI BioPharma Names A New CEO

  February 27, 2017

   · 

  5 min read
• Deals

  Johnson & Johnson Closes $4.3 Billion Buyout of Abbott Medical Optics

  February 27, 2017

   · 

  3 min read